Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

16 Sep 2015 07:00

RNS Number : 1669Z
Standard Life Euro Pri Eqty Tst PLC
16 September 2015
 



Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2015

 

· NAV rose by 1.6% to 273.0p for the quarter ended 30 June 2015

· Realised gains and income during the quarter ended 30 June 2015 were £13.0 million (3.1% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £5.9 million (1.4% of NAV); in addition, there were unrealised foreign exchange losses of £9.3 million (2.2% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2015

· NAV total return was 7.8% for the nine months from 1 October 2014 to 30 June 2015. This was after including unrealised foreign exchange losses of £31.5 million (7.7% of NAV)

· Outstanding commitments were £249.7 million at 30 June 2015

· Liquid resources were £53.6 million at 30 June 2015

 

For the quarter ended 30 June 2015 the Company's net asset value per ordinary share ("NAV") rose by 1.6% to 273.0p, from 268.6p at 31 March 2015. At 30 June 2015 the Company's net assets were £427.3 million (31 March 2015 - £422.5 million). NAV total return was 7.8% for the nine months from 1 October 2014 to 30 June 2015.

 

The volume of new buy-out transactions rose modestly in the European private equity market in the second quarter of 2015, while the enterprise value of buy-outs announced increased materially to €40.8 billion, from €16.7 billion in the first quarter of 2015. The material uplift reflected growth in mid-market and particularly large/mega buy-out transactions. The second quarter also witnessed strong mergers and acquisitions activity in Europe and a continuing flow of exits from private equity controlled investments.

 

The closing value of the Company's portfolio of 47 private equity fund interests was £373.8 million at 30 June 2015 (31 March 2015 - £375.1 million). The total unrealised losses on the portfolio for the quarter ended 30 June 2015 were £3.4 million, comprising £5.9 million of unrealised gains on a constant exchange rate basis and £9.3 million of unrealised foreign exchange losses. The £5.9 million of gains in the value of the portfolio on a constant exchange rate basis reflected positive earnings growth at many underlying portfolio companies, partially offset by a fall in listed equity markets. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 4.5% and 2.5% respectively during the quarter. The unrealised foreign exchange losses were driven by the euro and the US dollar depreciating by 2.1% and 5.9% respectively relative to sterling over the quarter.

 

During the quarter ended 30 June 2015 the Company funded £13.4 million of draw downs (six months ended 31 March 2015 - £37.8 million) and received £24.2 million of distributions (six months ended 31 March 2015 - £47.9 million). The distributions received during the quarter generated £13.0 million of realised gains and income, which was equivalent to a return of 2.2 times the acquisition cost of the realised investments. Total draw downs and distributions for the nine months ended 30 June 2015 were £51.2 million and £72.1 million, respectively.

 

The Company made one new fund commitment in the quarter, with a commitment of €30.0 million to Equistone Partners Europe Fund V. The Company had total outstanding commitments to its 47 private equity fund interests of £249.7 million at 30 June 2015 (31 March 2015 - £247.4 million). The Manager continues to believe that up to £50 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2015 the Company had liquid resources of £53.6 million, comprising a cash balance of £23.1 million and £30.5 million invested at value (£29.5 million at cost) in UK and European equity index tracker funds (31 March 2015 - liquid resources of £47.6 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

 

2. Activity since 30 June 2015

 

On 10 July 2015 the Company paid an interim dividend for the year ended 30 September 2015 of 1.75p per ordinary share.

 

During the period from 1 July to 15 September 2015 the Company funded £6.7 million of draw downs and received £32.3 million of distributions.

 

At 15 September 2015 the Company had liquid resources of £73.7 million, comprising a cash balance of £35.8 million and £37.9 million invested at value (£38.5 million at cost) in UK and European equity index tracker funds. The Company also had total outstanding commitments of £249.9 million.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2015 on or around 7 December 2015.

 

 

For further information please contact:-

 

Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDELFFEKFZBBQ
Date   Source Headline
7th Dec 20124:53 pmRNSTransaction in Own Shares
3rd Dec 20127:00 amRNSPreliminary Results
1st Oct 201210:48 amRNSQuarterly Disclosure
19th Sep 20127:00 amRNSQuarterly Trading Statement
17th Aug 201210:57 amRNSInterim Management Statement
9th Jul 20125:04 pmRNSHolding(s) in Company
9th Jul 201211:44 amRNSHolding(s) in Company
2nd Jul 20122:39 pmRNSQuarterly Disclosure
1st Jun 20124:56 pmRNSDirector/PDMR Shareholding
29th May 20125:28 pmRNSHalf Yearly Report
24th May 20129:10 amRNSDirector Declaration
2nd Apr 201212:43 pmRNSQuarterly Disclosure
21st Mar 20127:00 amRNSQuarterly Trading Statement
1st Mar 20129:47 amRNSTotal Voting Rights
24th Feb 20129:09 amRNSHolding(s) in Company
22nd Feb 20127:30 amRNSCompany Secretary Change
14th Feb 20122:18 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20124:45 pmRNSInterim Management Statement
2nd Feb 20124:40 pmRNSSecretary Change
2nd Feb 20124:35 pmRNSResult of AGM
2nd Feb 20124:27 pmRNSDirectorate Change
1st Feb 20129:21 amRNSIssue of Equity
30th Jan 201211:24 amRNSAnnual Financial Report
12th Jan 20124:46 pmRNSAnnual Information Update
11th Jan 20123:32 pmRNSScrip dividend reference price
5th Jan 201210:56 amRNSQuarterly Disclosure
16th Dec 201111:15 amRNSDoc re. Annual Report & Circular
12th Dec 201110:26 amRNSDirector/PDMR Shareholding
7th Dec 20113:42 pmRNSDirector/PDMR Shareholding
5th Dec 20114:19 pmRNSDirector/PDMR Shareholding
5th Dec 20112:20 pmRNSDirector/PDMR Shareholding
5th Dec 20117:00 amRNSPreliminary Results
29th Nov 20113:55 pmRNSHolding(s) in Company
11th Oct 201110:22 amRNSDirector Declaration
5th Oct 20117:00 amRNSManagement Incentive Scheme Arrangements
4th Oct 20114:17 pmRNSQuarterly Disclosure
21st Sep 20117:00 amRNSQuarterly Trading Statement
11th Aug 20117:00 amRNSInterim Management Statement
20th Jul 201110:48 amRNSHolding(s) in Company
4th Jul 20111:08 pmRNSQuarterly Disclosure
15th Jun 201110:31 amRNSDirector/PDMR Shareholding
14th Jun 20113:46 pmRNSDirector/PDMR Shareholding
2nd Jun 20119:26 amRNSReplacement - Half Yearly Report
27th May 20117:00 amRNSHalf Yearly Report
4th Apr 20112:57 pmRNSQuarterly Disclosure
1st Apr 20117:00 amRNSDirectorate Change
21st Mar 20113:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.